Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
about
Clostridium difficile infection in inflammatory bowel disease: challenges in diagnosis and treatment.Immune Responses to Broad-Spectrum Antibiotic Treatment and Fecal Microbiota Transplantation in Mice.Fecal Microbiota Transplantation: From Clostridium difficile to Inflammatory Bowel Disease.Effect of antibiotics on bacterial populations: a multi-hierachical selection process.The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future.Management of inflammatory bowel disease with Clostridium difficile infection.The Present Status of Fecal Microbiota Transplantation and Its Value in the Elderly.The potential role of fecal microbiota transplantation in the treatment of inflammatory Bowel disease.Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease.Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.The Neonatal Window of Opportunity: Setting the Stage for Life-Long Host-Microbial Interaction and Immune Homeostasis.The Risk of Inflammatory Bowel Disease Flares after Fecal Microbiota Transplantation: Systematic Review and Meta-Analysis.Vancomycin Taper and Risk of Failure of Fecal Microbiota Transplant in Patients With Recurrent Clostridium difficile Infection.Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease.Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in Patients With Inflammatory Bowel Disease: A Single-Center Experience.Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection.Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management.Faecal microbiota transplantation in patients with Clostridium difficile and significant comorbidities as well as in patients with new indications: A case series.Effect of Oral Capsule- vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.Metronidazole or Rifaximin for Treatment of Clostridium difficile in Pediatric Patients with Inflammatory Bowel Disease: A Randomized Clinical Trial.Fecal Microbiota Transplantation, Commensal Escherichia coli and Lactobacillus johnsonii Strains Differentially Restore Intestinal and Systemic Adaptive Immune Cell Populations Following Broad-spectrum Antibiotic Treatment.Mice with Inflammatory Bowel Disease are Susceptible to Clostridium difficile Infection With Severe Disease Outcomes.Faecal microbiota transplantation: looking beyond clostridium difficile infection at inflammatory bowel disease.Microbiota transplantation: concept, methodology and strategy for its modernization.Fecal microbiota transplantation and its potential therapeutic uses in gastrointestinal disorders.The Value of Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis Patients: A Systematic Review and Meta-Analysis.Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Infection in Immunocompromised Patients
P2860
Q30235905-8ED10F21-F7BA-4D2D-90FB-33BC0661BCA2Q33575993-42F29F72-4B85-4ABE-8453-5A5C4BDC2362Q33717111-80D9825A-40EE-4F8F-B2CB-19147D185C91Q37595457-9DCA1F1A-5E34-4088-8CE1-A973260E4977Q38600245-FE123749-1CF1-4E6C-A98A-FA2B985DF607Q38635974-29DACD76-8492-4D65-BC4E-888326BD5121Q38658559-AA273358-ACB0-48FE-BADF-5DA01282A7E4Q38661453-E68B6B3F-BA0A-4F15-8644-C398EC216C03Q38727911-C627C259-66E3-46D4-852B-8D735B65A0ACQ38795652-1BA34751-3EAE-4D97-B70E-85676E46ABC3Q39077395-257E1998-F2FB-4025-A015-5988F23C39E3Q39444977-048420D1-48F6-4E43-A5F6-451A116648AEQ40187487-2D86E42E-19B2-4F3A-AA81-40303DABCC08Q40234279-BD0343DA-FE39-4514-BA53-C1F91684F0C9Q40365743-26A751E6-78CB-4B92-9AB2-149DF16F4ECFQ40421362-55651523-C089-43DB-99D2-29D360E0D61CQ41996759-7D084337-1F15-45AE-9A72-7208A70A40DAQ46284784-F5A10E3D-3C2B-40A6-BCF4-EC4E7E557C77Q47112915-411B2A08-9F49-4AD6-8846-A300FE6F00DAQ47548289-6D6DBD23-65AC-49BF-BF1C-3983095EF54EQ47691053-166AB4FA-2199-4499-82E8-00BF14665742Q49442283-3143D1EE-BCA4-48C6-8799-595A626633B1Q50026548-BC793E1E-27DF-406A-A6E1-CDB9858D4B05Q52347023-CD20E4B9-4211-45E0-9EB7-B29AF0ABBED0Q52716963-7CAE163E-0315-44AC-B331-1061365A111DQ55241521-1BC08183-C83B-4A3F-A72F-0498DAC5CBA9Q55304582-FDD19F5F-13A2-4D31-AAA1-19E60E6119EEQ56225357-CABC0F5E-FB37-4D0B-BF24-8D5EDF4BA0EBQ58770112-F92547B1-96D6-4D9A-820E-63A1814481DF
P2860
Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Fecal Microbiota Transplantati ...... th Inflammatory Bowel Disease.
@en
Fecal Microbiota Transplantati ...... th Inflammatory Bowel Disease.
@nl
type
label
Fecal Microbiota Transplantati ...... th Inflammatory Bowel Disease.
@en
Fecal Microbiota Transplantati ...... th Inflammatory Bowel Disease.
@nl
prefLabel
Fecal Microbiota Transplantati ...... th Inflammatory Bowel Disease.
@en
Fecal Microbiota Transplantati ...... th Inflammatory Bowel Disease.
@nl
P2093
P2860
P921
P1476
Fecal Microbiota Transplantati ...... th Inflammatory Bowel Disease.
@en
P2093
Aishwarya Kuchipudi
Brian Sipe
Colleen Kelly
Emmalee Phelps
Harry Sokol
Huiping Xu
Jessica R Allegretti
Mark Blumenkehl
P2860
P304
P356
10.1097/MIB.0000000000000908
P50
P577
2016-08-30T00:00:00Z